This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Johnson & Johnson in US$297 million settlement with Texas over opioid-related claims
Johnson & Johnson and its US-based Janssen Pharmaceutical Companies have announced a settlement agreement with the State of
Texas and its participating subdivisions resolving their opioid-related claims against the company. Johnson & Johnson said
that with this agreement, the company is removed from the pending Texas state and subdivision litigation, including two bellwether
trials scheduled for early 2022.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.